Abstract-The nanopore-based single-molecule biosensor has been extensively investigated for various biomedical detections. It has demonstrated the potential in gene sequencing and diagnosis-oriented biomarker detection such as microRNAs. In real-time detection, however, samples extracted from bio-fluids contain various non-target nucleic acids components. These components can cause severely influence the target detection accuracy. We have discovered that a polycationic probe can solve this issue. The polycationic peptide domain of the probe can separate the target•probe complex from free nucleic acids, and only lead the complex into the pore, therefore realizing simultaneous enrichment and detection of target microRNAs. This study establishs a universal approach to detecting any short pathogenic nucleic acids fragment in complex samples
I. INTRODUCTION
Nanopores are a type of molecular scale pore structures fabricated in an insulating membrane. A transmembrane voltage applied can drive an ion current across the pore. Single molecules that interact with the nanopore can specifically block the ion pathway, resulting in characteristic change in the nanopore conductance, called signatures. The signature profile such as conductance level and duration is the identity of individual target molecules, while counting the number of signatures allows target quantification.
Nanopores have been developed as a powerful singlemolecule detector in life sciences exploration [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . In genetic detection, the nanopore represents a potential new generation technology for gene sequencing [15] [16] [17] [18] , and in epigenetic detection, the nanopore has been shown to be able to analyze DNA methylation [19] and gene damage [20] . We have utilized the nanopore to investigate single aptamer folding/unfolding mechanism and its regulation [21, 22] . In particular, the nanopore has been applied in quantification of microRNAs (miRNAs) [23, 24] , a group of extremely important small regulatory RNAs [25] [26] [27] [28] that are promising cancer biomarkers [29] [30] [31] [32] [33] [34] [35] [36] [37] . Therefore in the future the nanopore sensor could offer a non-invasive approach to cancer diagnostics. such as miRNAs, mRNAs, tRNA etc. All of these components have chances to bind the nanopore. Their interaction with the nanopore will cause contaminative nanopore signals that could severely influence the recognition and measurement of target microRNA signals. Therefore, a priority in real-time applications is eliminating these interferences.
Here we uncovered that this issue can be universally solved by using a unique polycationic probe. This probe can simultaneously enrich and detect the target microRNA in the presence of non-target nucleic acids (Fig. 1) . The probe contains a peptide nucleic acids (PNA) attached with a polycationic peptide lead. When the target microRNA is bound by PNA, the peptide lead can drives the complex moving toward the nanopore in the electrical field, whereas any free nucleic acids without probe binding carry negative charge, thus migrate against the pore. Therefore only the target microRNA is enriched around the nanopore opening, and simultaneously detected from the signatures generated by the microRNA•probe complex. There will be no any interference signal originating from free nucleic acids. This simple and universal approach, once validated, could be expanded to detect any short pathogenic nucleic acids in complex samples. 
II. RESULTS

A. Identifying microRNA with a polycationic probe
We selected microRNA Let-7b as the target to test this proof-of-concept. The PNA domain of the probe P 7b is fully matched with the 3' 10 bases of Let-7b. The cationic peptide domain of P 7b contains 11 amino acids, including 6 arginines and 2 lysines. Both Let-7b and P 7b was presented in trans side of the multant α-hemolysin protein pore K131D. Trans opening of this pore has been constructed with an anionic Asp 131 ring to attract cationic molecules. A positive voltage was applied from trans side with cis side grounded. In this configuration, only cationic molecules in trans solution can move toward the pore, while anionic molecules move oppositely against the pore. Table 1 . Sequences of microRNAs and probe in this study
The current trace in Fig. 2a shows that Let-7b alone in never blocked the pore under a positive voltage, suggesting that anionic microRNA was prevented from interacting with the pore. In contrast, the current trace in Fig. 2b shows that the robe P 7b alone in trans solution produced a large number of Level 1 blocks, due to the negative charge on the peptide that drives the polymer toward the nanopore. These blocks with duration of 4.8 ms reduced the pore conductance to 8.2% (Fig. 2d upper) . However, when the Let-7b / P 7b mixture was added in trans solution, as Fig. 2c , Level 1 blocks were replaced with a large number of distinct Level 2 blocks. By comparison, the Level 2 block duration was prolonged by 4 times to 21 ms, and featured a higher residual conductance to 26% (Fig. 2d lower) . Because the Level 2 blocks were only observed in the Let-7b/P 7b mixture, they should be generated by the Let-7b•P 7b complex that binds with the pore from trans entrance. Therefore Level 2 blocks can serve as the signature for Let-7b identification. 
B. Configuration for microRNA•probe complex in nanopore
The molecular configuration for the Let-7b•P 7b complex in the pore is proposed in Fig. 3a . When the Let-7b•P 7b complex interacts with the pore, the peptide domain (~1.7 nm wide) of the complex will enter the pore from trans entrance (~2 nm), while the wider Let-7b•PNA duplex domain (~2.3 nm) is anchored at the entrance without entering the pore. This configuration suggests that the Level 2 signature is generated by the peptide domain occupying the pore's β-barrel. Because the duration of Level 2 blocks was consistently extended as the voltage increased (data not shown), it is expected that the trapped Let-7b•P 7b complex is released back to trans solution at the end of Level 2, rather than translocates through the pore. Distinguished from Level 2, the Level 1 block conductance is contributed by trapping the entire P 7b in the pore (Fig. 3b) . PNA itself can be rarely trapped in the pore, so the trapping of PNA should be led by the peptide domain. 
C. Single-base discrimination between different microRNAs
Disease diagnosis demands the nanopore sensor to be able to accurately determine microRNAs with similar sequences. We further uncovered that the PNA-peptide probe designed as above can build this capability to the nanopore sensor. In this study, the probe P 7b was used to target microRNAs Let-7b and Let-7c. Both microRNAs in Let-7 family are different in one base at position 16. Thus the Let7c•P 7b hybrid contains a single mismatched base pair (Table  1) . Current traces in Fig. 4 show the duration of Level 2 signatures for fully-matched Let-7b•P 7b was 380 ms (+130 mV in 3 M/0.5 M cis/trans KCl), whereas the duration was shortened over 30 times to 12 ms for one-mismatched Let7c•P 7b complex. Also the Let-7c•P 7b signatures featured two block levels, distinct from Let-7b•P 7b 's single-level block. This suggests a different configuration for Let-7c•P 7b in the pore: Driven by the voltage, Let-7c•P 7b is de-hybridized in the pore. After de-hybridization, the free Let-7c returns to trans solution, but P 7b passes through the pore, stepwise changing the conductance. Overall, the fully-matched miRNA•PNA duplex is sufficiently stable to resist dehybridization, while a single mismatch introduced in duplex significantly destabilizes the hybridization. This generates the 30 folds difference in block duration and distinct block profiles between two microRNAs, enabling us to accurately discriminate single Let-7b and Let-7c molecules by eyes. 
D. Optimized pore and probe for enhanced sensitivity
We finally investigated the sensitivity of the nanopore sensor. It was found that both probe design and nanopore engineering enables high sensitivity in microRNA detection. The anionic Asp 131 ring constructed at the trans entrance of the K131D pore can effectively attract cationic peptide. As a result, the target capture rate can be greatly enhanced. The capture rate for P 7b (peptide-PNA) was sharply increased by 90-fold from 3.2 μM . This capture rate is 50-fold enhanced compared microRNA detection with a DNA probe in our earlier study [23] . Therefore the combined design polycationic probe and engineered nanopore can greatly enhance the microRNA capture rate.
Moreover, the frequency of Let-7b•P 7b signatures consistently increases along with the Let-7b concentration in a broad range from 50 pM to 5 nM (+180 mV, Fig. 5 ), and the data can be fitted to a straight line in the log-log scale. This result suggests the concentration-dependent frequency plot can be used for sensor calibration in microRNA detection. 
III. CONCLUSIONS AND PERSPECTIVES
In summary, we have discovered that a polycationic probe can realize simultaneous enrichment and detection of microRNAs in the nanopore. The positively charged domain of the probe can separate the microRNA•probe complex from free nucleic acids, and only lead the complex into the pore. PNA in the probe has been broadly applied in molecular biology, diagnostic assays and antisense therapies due to the guaranteed binding strength and specificity [38] [39] [40] [41] . The use of PNA offers greater specificity in detecting miRNAs with single-nucleotide difference. The polycationic peptide domain of the probe realizes 1) separating the probe-bound microRNA from free nucleic acids for enrichment, 2) trapping the microRNA•probe complex into the nanopore, and 3) enhancing the sensitivity by promoting the capture rate. The peptide's sequence and structure are programmable by tuning the polymer length and in particular the number of charged amino acids and their positions in the sequence. There are many chemical methods available to modify the peptide property, in order to generate varying signatures for multiplex microRNA detection. This simple nanopore method is universal to detecting any short pathogenic DNA or RNA fragments for disease prediction, dianostics and prognostics.
